This invention features methods for treating diseases associated with mutations in the CFTR gene by administering PPAR agonists, specifically PPAR.gamma., PPAR.alpha., and PPAR.delta. agonists, PPAR inducers, and/or antioxidants. Also disclosed are screening methods for identifying therapeutically useful candidate compounds.